Capri Global Capital Reports No Deviations in Fund Utilisation for Quarter Ended March 31, 2026
Capri Global Capital Limited filed its Regulation 32(1) SEBI compliance statement on May 05, 2026, confirming no deviations in fund utilisation for the quarter ended March 31, 2026. The disclosure covers ten NCD instruments raised through private placements and one public issue, with all proceeds utilised per stated objectives. Audit Committee comments and auditor remarks were NIL across all instruments.

*this image is generated using AI for illustrative purposes only.
Capri Global Capital Limited has submitted its Statement of Deviation or Variation in the utilisation of fund-raising proceeds for the quarter ended March 31, 2026, in compliance with Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was filed with both BSE Limited and the National Stock Exchange of India Limited on May 05, 2026. The company confirmed that there are no deviations or variations in the utilisation of proceeds across all reported instruments.
Fund-Raising Instruments Covered
The statement covers ten Non-Convertible Debenture (NCD) instruments raised through a combination of private placement and one public issue. The details of each instrument are presented below:
| Instrument No. | Mode of Fund Raising | Date of Raising Funds | Amount Raised |
|---|---|---|---|
| 1 | Private Placement | August 9, 2019 | Rs. 150 Crore |
| 2 | Private Placement | March 28, 2025 | Rs. 20 Crore |
| 3 | Private Placement | April 29, 2025 | Rs. 50 Crore |
| 4 | Private Placement | July 08, 2025 | Rs. 100 Crore |
| 5 | Private Placement | November 24, 2025 | Rs. 50 Crore |
| 6 | Private Placement | December 01, 2025 | Rs. 20 Crore |
| 7 | Private Placement | January 28, 2026 | Rs. 100 Crore |
| 8 | Private Placement | March 25, 2026 | Rs. 47 Crore |
| 9 | Private Placement | March 25, 2026 | Rs. 20 Crore |
| 10 | Public Issue | October 13, 2025 | Rs. 400 Crore |
Stated Objects of Fund Utilisation
Each instrument was raised for specific business purposes, and the company has confirmed that all proceeds have been utilised in accordance with the originally stated objects. The stated purposes across the instruments include:
- Instrument 1 (August 9, 2019): Financing activities, repaying existing loans, and business operations
- Instruments 2 & 3: Onward lending purposes, refinancing, working capital requirements, and general corporate purpose
- Instruments 4, 5 & 6: Onward lending purposes and other general corporate purpose
- Instrument 7: Onward lending purposes, refinancing of existing facilities, and other general corporate purpose
- Instruments 8 & 9: Onward lending purposes, refinancing, working capital requirements, and other general corporate purpose
- Instrument 10 (Public Issue): Onward lending, financing, repayment of interest and principal of existing borrowings, and general corporate purposes
Compliance and Audit Observations
For all ten instruments, the company reported no deviation or variation in the use of funds raised. No modifications to the original objects were made, and no shareholder approval for any change in contract terms was required. The Audit Committee's comments and auditor remarks are recorded as NIL for each instrument, indicating no concerns were raised during the review process. No monitoring agency was applicable for any of the instruments covered in this statement.
The disclosure has been signed by Yashesh Bhatt, Company Secretary & Compliance Officer (Membership No.: A20491), on behalf of Capri Global Capital Limited. The statement is also available on the company's website at www.capriloans.in .
Historical Stock Returns for Capri Global Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.19% | +8.96% | +20.97% | +1.34% | +20.93% | +89.06% |
Given Capri Global Capital's accelerating NCD issuance pace in late 2025 and early 2026, what sectors or borrower segments is the company targeting for its expanded onward lending portfolio?
How might Capri Global Capital's Rs. 400 Crore public NCD issue performance influence its strategy for future retail debt fundraising versus private placements?
With significant refinancing activity across multiple instruments, how is Capri Global Capital managing its interest rate risk exposure amid evolving RBI monetary policy?


































